rel-(1R,3S)-1-(Aminomethyl)-3-phenylisochromane-5,6-diol hydrochloride

Catalog No. :
ACOLMC803
CAS No. :
130465-39-3
Molecular Formula :
C16H18ClNO3
Molecular Weight :
307.78

IUPAC Name:(1R,3S)-1-(aminomethyl)-3-phenylisochromane-5,6-diol hydrochloride

rel-(1R,3S)-1-(Aminomethyl)-3-phenylisochromane-5,6-diol hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$766.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namerel-(1R,3S)-1-(Aminomethyl)-3-phenylisochromane-5,6-diol hydrochloride
IUPAC Name(1R,3S)-1-(aminomethyl)-3-phenylisochromane-5,6-diol hydrochloride
MDL No.MFCD05863727
Molecular FormulaC16H18ClNO3
Molecular Weight307.78
SMILESOC1=C2C[C@@H](C3=CC=CC=C3)O[C@@H](CN)C2=CC=C1O.[H]Cl
InChI KeyPQPGUUQPTSMLKU-YYLIZZNMSA-N
SynonymA 68930 HYDROCHLORIDE;CIS-(+/-)-1-(AMINOMETHYL)-3,4-DIHYDRO-3-PHENYL-1H-2-BENZOPYRAN-5,6-DIOL HYDROCHLORIDE;A 68930;A68930HCl;cis-(±)-1-Aminoethyl-3,4-dihydro-3-phenyl-1H-2-benzopyran-5,6-diol hydrochloride;cis-1-(AMinoMethyl)-3-phenylisochroMan-5,6-diol hydrochloride;(1R,3S)-1-(AMinoMethyl)-3-phenylisochroMan-5,6-diol hydrochloride;1-(aminomethyl)-3,4-dihydro-3-phenyl-1H-2-Benzopyran-5,6-diol hydrochloride
CAS No.130465-39-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACOLMC803 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOLMC803 route product structure diagram
    ACOLMC803130465-39-3
Inquiry

2. ACOLMC803 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOLMC803 route product structure diagram
    ACOLMC803130465-39-3
Inquiry

Comments (0)